Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 244

1.

Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma - a LWP-EBMT study.

Bazarbachi A, Boumendil A, Finel H, Castagna L, Dominietto A, Blaise D, Diez-Martin JL, Tischer J, Gülbas Z, Wallet HL, Corral LL, Mohty M, Koc Y, Yakoub-Agha I, Schmid C, El Cheikh J, Arat M, Forcade E, Dreger P, Rocha V, García GG, Chalandon Y, Ferra C, Orvain C, Robinson S, Montoto S, Sureda A.

Br J Haematol. 2019 Sep 9. doi: 10.1111/bjh.16182. [Epub ahead of print]

PMID:
31498883
2.

Relapsed refractory multiple myeloma: a comprehensive overview.

Bazarbachi AH, Al Hamed R, Malard F, Harousseau JL, Mohty M.

Leukemia. 2019 Aug 27. doi: 10.1038/s41375-019-0561-2. [Epub ahead of print] Review.

PMID:
31455853
3.

Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic stem cell transplantation program in countries with limited resources (Part II): Clinical, technical and socio-economic considerations.

Aljurf M, Weisdorf D, Hashmi SK, Nassar A, Gluckman E, Mohty M, Rizzo D, Pasquini M, Hamadani M, Saber W, Hari P, Kharfan-Dabaja M, Majhail N, Gerges U, Ali Hamidieh A, Hussain F, Elhaddad A, Mahmoud HK, Tbakhi A, Othman TB, Hamladji RM, Bekadja MA, Ahmed P, Bazarbachi A, Adil S, Alkindi S, Ladeb S, Dennison D, Patel M, Lu P, Quessar AE, Okamoto S, Atsuta Y, Alhejazi A, Ayas M, Ahmed SO, Novitsky N, Srivastava A, Seber A, Elsolh H, Ghavamzadeh A, Confer D, Kodera Y, Greinix H, Szer J, Horowitz M, Niederwieser D.

Hematol Oncol Stem Cell Ther. 2019 Aug 20. pii: S1658-3876(19)30055-X. doi: 10.1016/j.hemonc.2019.08.002. [Epub ahead of print]

4.

Personalizing rabbit anti-thymocyte globulin therapy for prevention of graft-versus-host disease after allogeneic hematopoietic cell transplantation: is there an optimal dose?

Shichijo T, Fuji S, Nagler A, Bazarbachi A, Mohty M, Savani BN.

Bone Marrow Transplant. 2019 Aug 21. doi: 10.1038/s41409-019-0643-9. [Epub ahead of print] Review.

PMID:
31435032
5.

A Critical Review of Animal Models Used in Acute Myeloid Leukemia Pathophysiology.

Skayneh H, Jishi B, Hleihel R, Hamieh M, Darwiche N, Bazarbachi A, El Sabban M, El Hajj H.

Genes (Basel). 2019 Aug 13;10(8). pii: E614. doi: 10.3390/genes10080614. Review.

6.

Complete remission of seronegative rheumatoid arthritis following haplo-identical stem cell transplantation for peripheral T-cell lymphoma.

Atoui A, El Labban M, Ghaoui N, El Darsa H, Cheikh J, Bazarbachi A.

Bone Marrow Transplant. 2019 Aug 12. doi: 10.1038/s41409-019-0635-9. [Epub ahead of print] No abstract available.

PMID:
31406225
7.

Allogeneic stem cell transplantation for acquired pure red cell aplasia.

Halkes C, de Wreede LC, Knol C, Simand C, Aljurf M, Tbakhi A, Vazquez L, Bloor A, Wagner-Drouet E, Vural F, Bodova I, Isaksson C, Diaz MÁ, Gruhn B, Snowden J, Arat M, Bazarbachi A, Spilleboudt C, Kulagin A, Marsh JC, Passweg J, Risitano AM, Peffault de Latour R, Dufour C; European Society for Blood and Marrow Transplantation Severe Aplastic Anemia Working Party.

Am J Hematol. 2019 Aug 8. doi: 10.1002/ajh.25609. [Epub ahead of print] No abstract available.

PMID:
31396977
8.

Mutant H3 histones drive human pre-leukemic hematopoietic stem cell expansion and promote leukemic aggressiveness.

Boileau M, Shirinian M, Gayden T, Harutyunyan AS, Chen CCL, Mikael LG, Duncan HM, Neumann AL, Arreba-Tutusaus P, De Jay N, Zeinieh M, Rossokhata K, Zhang Y, Nikbakht H, Mouawad C, Massoud R, Frey F, Nasr R, El Cheikh J, El Sabban M, Kleinman CL, Mahfouz R, Minden MD, Jabado N, Bazarbachi A, Eppert K.

Nat Commun. 2019 Jun 28;10(1):2891. doi: 10.1038/s41467-019-10705-z.

9.

Efficacy of Allogeneic Hematopoietic Cell Transplantation in Human T Cell Lymphotropic Virus Type 1-Associated Adult T Cell Leukemia/Lymphoma: Results of a Systematic Review/Meta-Analysis.

Iqbal M, Reljic T, Klocksieben F, Sher T, Ayala E, Murthy H, Bazarbachi A, Kumar A, Kharfan-Dabaja MA.

Biol Blood Marrow Transplant. 2019 Aug;25(8):1695-1700. doi: 10.1016/j.bbmt.2019.05.027. Epub 2019 May 25.

PMID:
31132453
10.

Efficacy and Feasibility of Sorafenib as a Maintenance Agent After Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Mutated Acute Myeloid Leukemia: An Update.

Battipaglia G, Massoud R, Ahmed SO, Legrand O, El Cheikh J, Youniss R, Aljurf M, Mohty M, Bazarbachi A.

Clin Lymphoma Myeloma Leuk. 2019 Aug;19(8):506-508. doi: 10.1016/j.clml.2019.04.004. Epub 2019 Apr 18.

PMID:
31122828
11.

Complete sequence of human T cell leukemia virus type 1 in ATLL patients from Northeast Iran, Mashhad revealed a prematurely terminated protease and an elongated pX open reading frame III.

Mirhosseini A, Mohareri M, Arab R, Rezaee SA, Shirdel A, Koshyar MM, Allahyari A, Bari A, Rahimi H, Mozaheb Z, Bazarbachi A, Boostani R, Mashkani B, Rafatpanah H.

Infect Genet Evol. 2019 Sep;73:460-469. doi: 10.1016/j.meegid.2019.05.012. Epub 2019 May 16.

PMID:
31102740
12.

Validation of a Drosophila model of wild type and T315I mutated BCR-ABL1 in chronic myeloid leukemia: An effective platform for treatment screening.

Al Outa A, Abubaker D, Bazarbachi A, El Sabban M, Shirinian M, Nasr R.

Haematologica. 2019 May 17. pii: haematol.2019.219394. doi: 10.3324/haematol.2019.219394. [Epub ahead of print]

13.

Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)-an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT).

Kansagra AJ, Frey NV, Bar M, Laetsch TW, Carpenter PA, Savani BN, Heslop HE, Bollard CM, Komanduri KV, Gastineau DA, Chabannon C, Perales MA, Hudecek M, Aljurf M, Andritsos L, Barrett JA, Bachanova V, Bonini C, Ghobadi A, Gill SI, Hill JA, Kenderian S, Kebriaei P, Nagler A, Maloney D, Liu HD, Shah NN, Kharfan-Dabaja MA, Shpall EJ, Mufti GJ, Johnston L, Jacoby E, Bazarbachi A, DiPersio JF, Pavletic SZ, Porter DL, Grupp SA, Sadelain M, Litzow MR, Mohty M, Hashmi SK.

Bone Marrow Transplant. 2019 May 15. doi: 10.1038/s41409-019-0451-2. [Epub ahead of print]

PMID:
31092900
14.
15.

Antitumor efficacy of arsenic/interferon in preclinical models of chronic myeloid leukemia resistant to tyrosine kinase inhibitors.

El Eit R, Itani AR, Nassar F, Rasbieh N, Jabbour M, Santina A, Zaatari G, Mahon FX, Bazarbachi A, Nasr R.

Cancer. 2019 Aug 15;125(16):2818-2828. doi: 10.1002/cncr.32130. Epub 2019 Apr 29.

PMID:
31034603
16.

Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries with Limited Resources, Part II: Clinical, Technical, and Socioeconomic Considerations.

Aljurf M, Weisdorf D, Hashmi S, Nassar A, Gluckman E, Mohty M, Rizzo D, Pasquini M, Hamadani M, Saber W, Hari P, Kharfan-Dabaja M, Majhail N, Gerges U, Hamidieh AA, Hussain F, Elhaddad A, Mahmoud HK, Tbakhi A, Othman TB, Hamladji RM, Bekadja MA, Ahmed P, Bazarbachi A, Adil S, Alkindi S, Ladeb S, Dennison D, Patel M, Lu P, Quessar AE, Okamoto S, Atsuta Y, Alhejazi A, Ayas MF, Ahmed SO, Novitzky N, Srivastava A, Seber A, Solh HE, Ghavamzadeh A, Confer D, Kodera Y, Hildegard G, Szer J, Horowitz MM, Niederwieser D.

Biol Blood Marrow Transplant. 2019 Apr 17. pii: S1083-8791(19)30235-6. doi: 10.1016/j.bbmt.2019.04.012. [Epub ahead of print] Review.

PMID:
31002990
17.

Current status of autologous stem cell transplantation for multiple myeloma.

Al Hamed R, Bazarbachi AH, Malard F, Harousseau JL, Mohty M.

Blood Cancer J. 2019 Apr 8;9(4):44. doi: 10.1038/s41408-019-0205-9. Review.

18.

Impact of cyclosporine A concentration on acute graft-vs-host disease incidence after haploidentical hematopoietic cell transplantation.

Stocker N, Duléry R, Battipaglia G, Brissot E, Médiavilla C, Sestili S, Paviglianiti A, Ledraa T, Mohty R, Bazarbachi A, Belhocine R, Vekhoff A, Ruggeri A, Mohty M, Malard F.

Eur J Haematol. 2019 Jul;103(1):10-17. doi: 10.1111/ejh.13233. Epub 2019 May 14.

PMID:
30958904
19.

Sorafenib improves survival of FLT3-mutated acute myeloid leukemia in relapse after allogeneic stem cell transplantation: a report of the EBMT Acute Leukemia Working Party.

Bazarbachi A, Labopin M, Battipaglia G, Djabali A, Passweg J, Socié G, Forcade E, Blaise D, Chevallier P, Orvain C, Cornelissen JJ, Arcese W, Chantepie S, Hashaishi K, Cheikh JE, Medinger M, Esteve J, Nagler A, Mohty M.

Haematologica. 2019 Sep;104(9):e398-e401. doi: 10.3324/haematol.2018.211615. Epub 2019 Feb 21. No abstract available.

20.

Successful treatment of severe aplastic anemia with syngeneic stem cell transplantation in the setting of active disseminated mucormycosis.

El-Cheikh J, Atoui A, Moukalled N, Ghaoui N, El Darsa H, Kanj SS, Bazarbachi A.

Med Mycol Case Rep. 2019 Jan 12;23:68-71. doi: 10.1016/j.mmcr.2019.01.001. eCollection 2019 Mar.

21.

Molecular profiling of adult acute myeloid and lymphoid leukemia in a major referral center in Lebanon: a 10-year experience report and review of the literature.

Assaf N, El-Cheikh J, Bazarbachi A, Salem Z, Farra C, Chakhachiro Z, Nassif S, Zaatari G, Mahfouz R.

Mol Biol Rep. 2019 Apr;46(2):2003-2011. doi: 10.1007/s11033-019-04649-2. Epub 2019 Jan 30.

PMID:
30701458
22.

Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report.

Cook LB, Fuji S, Hermine O, Bazarbachi A, Ramos JC, Ratner L, Horwitz S, Fields P, Tanase A, Bumbea H, Cwynarski K, Taylor G, Waldmann TA, Bittencourt A, Marcais A, Suarez F, Sibon D, Phillips A, Lunning M, Farid R, Imaizumi Y, Choi I, Ishida T, Ishitsuka K, Fukushima T, Uchimaru K, Takaori-Kondo A, Tokura Y, Utsunomiya A, Matsuoka M, Tsukasaki K, Watanabe T.

J Clin Oncol. 2019 Mar 10;37(8):677-687. doi: 10.1200/JCO.18.00501. Epub 2019 Jan 18.

23.

Physical therapy pathway and protocol for patients undergoing hematopoietic stem cell transplantation: Recommendations from The Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) Group.

Mohammed J, Aljurf M, Althumayri A, Almansour M, Alghamdi A, Hamidieh AA, ElHaddad A, Othman TB, Bazarbachi A, Almohareb F, Alzahrani M, Alkindi SS, Alsharif F, Da'na W, Alhashmi H, Bekadja MA, Al-Shammari SH, El Quessar A, Satti TM, Aljohani N, Rasheed W, Ghavamzadeh A, Chaudhri N, Hashmi SK.

Hematol Oncol Stem Cell Ther. 2019 Jan 11. pii: S1658-3876(18)30122-5. doi: 10.1016/j.hemonc.2018.12.003. [Epub ahead of print] Review.

24.

Correction to: Mucormycosis in hospitalized patients at a tertiary care center in Lebanon: a case series.

Zein SE, El-Cheikh J, Zakhem AE, Ibrahim D, Bazarbachi A, Kanj SS.

Infection. 2019 Apr;47(2):335. doi: 10.1007/s15010-018-1259-5.

PMID:
30617837
25.

Sarcopenic obesity derived from PET/CT predicts mortality in lymphoma patients undergoing hematopoietic stem cell transplantation.

Jabbour J, Manana B, Zahreddine A, Saade C, Charafeddine M, Bazarbachi A, Blaise D, El-Cheikh J.

Curr Res Transl Med. 2019 Aug;67(3):93-99. doi: 10.1016/j.retram.2018.12.001. Epub 2018 Dec 21.

PMID:
30583985
26.

Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation.

Kansagra AJ, Frey NV, Bar M, Laetsch TW, Carpenter PA, Savani BN, Heslop HE, Bollard CM, Komanduri KV, Gastineau DA, Chabannon C, Perales MA, Hudecek M, Aljurf M, Andritsos L, Barrett JA, Bachanova V, Bonini C, Ghobadi A, Gill SI, Hill J, Kenderian S, Kebriaei P, Nagler A, Maloney D, Liu HD, Shah NN, Kharfan-Dabaja MA, Shpall EJ, Mufti GJ, Johnston L, Jacoby E, Bazarbachi A, DiPersio JF, Pavletic SZ, Porter DL, Grupp SA, Sadelain M, Litzow MR, Mohty M, Hashmi SK.

Biol Blood Marrow Transplant. 2019 Mar;25(3):e76-e85. doi: 10.1016/j.bbmt.2018.12.068. Epub 2018 Dec 18.

PMID:
30576834
27.

Haploidentical related donor allogeneic hematopoietic stem cell transplantation for patient aged older than 76 years with refractory acute myeloid leukemia.

El-Cheikh J, Salem R, Massoud R, Salem C, Ghaoui N, Kanj SS, Mahfouz R, Bazarbachi A.

Hematol Oncol Stem Cell Ther. 2018 Dec 9. pii: S1658-3876(18)30119-5. doi: 10.1016/j.hemonc.2018.11.005. [Epub ahead of print] No abstract available.

28.

PAX5, NOTCH3, CBFB, and ACD drive an activated RAS pathway and monosomy 7 to B-ALL and AML in donor cell leukemia.

Assi R, Mahfouz R, Owen R, Gunthorpe M, Chehab FF, Bazarbachi A.

Bone Marrow Transplant. 2019 Jul;54(7):1124-1128. doi: 10.1038/s41409-018-0419-7. Epub 2018 Dec 10. No abstract available.

PMID:
30532056
29.

Medical research productivity in the Arab countries: 2007-2016 bibliometric analysis.

El Rassi R, Meho LI, Nahlawi A, Salameh JS, Bazarbachi A, Akl EA.

J Glob Health. 2018 Dec;8(2):020411. doi: 10.7189/jogh.08.020411.

30.

Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party.

Bazarbachi A, Boumendil A, Finel H, Mohty M, Castagna L, Blaise D, Peggs KS, Afanasyev B, Diez-Martin JL, Corradini P, Michonneau D, Robinson S, Gutiérrez García G, Bonifazi F, Yakoub-Agha I, Gülbas Z, Bloor A, Delage J, Esquirol A, Malladi R, Scheid C, El-Cheikh J, Ghesquières H, Montoto S, Dreger P, Sureda A.

Cancer. 2019 Jan 1;125(1):90-98. doi: 10.1002/cncr.31755. Epub 2018 Oct 23.

31.

The impact of counseling on nutritional status among hematopoietic stem cell recipients: results of a randomized controlled trial.

Jabbour J, Manana B, Sakr M, Zahreddine A, Tamim H, Bazarbachi A, Blaise D, El-Cheikh J.

Bone Marrow Transplant. 2019 May;54(5):752-756. doi: 10.1038/s41409-018-0366-3. Epub 2018 Oct 22. No abstract available.

PMID:
30349039
32.

Feasibility of Venetoclax-based combinations for adult patients with acute myeloid leukemia relapsing after allogenic stem cell transplantation.

Moukalled NM, El Darsa H, Haibe Y, Massoud R, Kanj SS, Mahfouz R, Bazarbachi A, El-Cheikh J.

Bone Marrow Transplant. 2019 Apr;54(4):620-624. doi: 10.1038/s41409-018-0347-6. Epub 2018 Oct 4. No abstract available.

PMID:
30287936
33.

Correction to: Mucormycosis in hospitalized patients at a tertiary care center in Lebanon: a case series.

El Zein S, El-Sheikh J, Zakhem A, Ibrahim D, Bazarbachi A, Kanj SS.

Infection. 2018 Dec;46(6):905. doi: 10.1007/s15010-018-1203-8.

PMID:
30218310
34.

Site specific diagnostic yield of endoscopic biopsies in Gastrointestinal Graft-versus-Host Disease: A tertiary care Center experience.

Daniel F, Hassoun L, Husni M, Sharara A, Soweid A, Barada K, Haffar B, Massoud R, Shaib Y, Al-Hashash J, Bazarbachi A, El Cheikh J.

Curr Res Transl Med. 2019 Feb;67(1):16-19. doi: 10.1016/j.retram.2018.08.001. Epub 2018 Sep 8.

PMID:
30206046
35.

Feasibility of the Combination of Venetoclax and Asparaginase-based Chemotherapy for Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia.

El-Cheikh J, Moukalled NM, El Darsa H, Massoud R, Kanj SS, Mahfouz R, Bazarbachi A.

Clin Lymphoma Myeloma Leuk. 2018 Oct;18(10):e441-e444. doi: 10.1016/j.clml.2018.07.289. Epub 2018 Aug 27. No abstract available.

PMID:
30166258
36.

Mucormycosis in hospitalized patients at a tertiary care center in Lebanon: a case series.

El Zein S, El-Cheikh J, El Zakhem A, Ibrahim D, Bazarbachi A, Kanj SS.

Infection. 2018 Dec;46(6):811-821. doi: 10.1007/s15010-018-1195-4. Epub 2018 Aug 18. Erratum in: Infection. 2018 Sep 14;:. Infection. 2019 Jan 7;:.

PMID:
30121719
37.

Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse.

Kharfan-Dabaja MA, Labopin M, Polge E, Nishihori T, Bazarbachi A, Finke J, Stadler M, Ehninger G, Lioure B, Schaap N, Afanasyev B, Yeshurun M, Isaksson C, Maertens J, Chalandon Y, Schmid C, Nagler A, Mohty M.

JAMA Oncol. 2018 Sep 1;4(9):1245-1253. doi: 10.1001/jamaoncol.2018.2091.

38.

Future Perspectives on Drug Targeting in Adult T Cell Leukemia-Lymphoma.

Marino-Merlo F, Mastino A, Grelli S, Hermine O, Bazarbachi A, Macchi B.

Front Microbiol. 2018 May 9;9:925. doi: 10.3389/fmicb.2018.00925. eCollection 2018. Review.

39.

The HTLV-1 oncoprotein Tax is modified by the ubiquitin related modifier 1 (Urm1).

Hleihel R, Khoshnood B, Dacklin I, Omran H, Mouawad C, Dassouki Z, El-Sabban M, Shirinian M, Grabbe C, Bazarbachi A.

Retrovirology. 2018 Apr 17;15(1):33. doi: 10.1186/s12977-018-0415-4.

40.

Mouse Models That Enhanced Our Understanding of Adult T Cell Leukemia.

Moodad S, Akkouche A, Hleihel R, Darwiche N, El-Sabban M, Bazarbachi A, El Hajj H.

Front Microbiol. 2018 Mar 28;9:558. doi: 10.3389/fmicb.2018.00558. eCollection 2018. Review.

41.

Thiotepa 10 mg/kg Treatment Regimen Is Superior to Thiotepa 5 mg/kg in TBF Conditioning in Patients Undergoing Allogeneic Stem-Cell Transplantation.

El-Cheikh J, Massoud R, Moukalled N, Haffar B, Assi H, Zahreddine A, Mahfouz R, Bazarbachi A.

Clin Lymphoma Myeloma Leuk. 2018 May;18(5):368-374. doi: 10.1016/j.clml.2018.02.016. Epub 2018 Mar 1.

PMID:
29625929
42.

Stability of HTLV-2 antisense protein is controlled by PML nuclear bodies in a SUMO-dependent manner.

Dubuisson L, Lormières F, Fochi S, Turpin J, Pasquier A, Douceron E, Oliva A, Bazarbachi A, Lallemand-Breitenbach V, De Thé H, Journo C, Mahieux R.

Oncogene. 2018 May;37(21):2806-2816. doi: 10.1038/s41388-018-0163-x. Epub 2018 Mar 6.

PMID:
29507418
43.

Brentuximab vedotin prior to allogeneic stem cell transplantation in Hodgkin lymphoma: a report from the EBMT Lymphoma Working Party.

Bazarbachi A, Boumendil A, Finel H, Mohty M, Castagna L, Peggs KS, Blaise D, Afanasyev B, Diez-Martin JL, Sierra J, Bloor A, Martinez C, Robinson S, Malladi R, El-Cheikh J, Corradini P, Montoto S, Dreger P, Sureda A.

Br J Haematol. 2018 Apr;181(1):86-96. doi: 10.1111/bjh.15152. Epub 2018 Feb 22.

PMID:
29468647
44.

Better outcome with haploidentical over HLA-matched related donors in patients with Hodgkin's lymphoma undergoing allogeneic haematopoietic cell transplantation-a study by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy.

Gauthier J, Poiré X, Gac AC, Leclerc M, Guillaume T, Chalandon Y, Nguyen S, Forcade E, Régny C, Bay JO, Bazarbachi A, Rohrlich PS, Huynh A, Farhi J, Marchand T, Malfuson JV, Pilorge S, Labussière-Wallet H, Renard C, Fornecker LM, Detrait M, Duléry R, Delage J, Ménard AL, Charbonnier A, Nelken B, Jubert C, Suarez F, de la Tour RP, Beguin Y, Schoemans H, Blaise D, Yakoub-Agha I.

Bone Marrow Transplant. 2018 Apr;53(4):400-409. doi: 10.1038/s41409-017-0018-z. Epub 2018 Jan 12.

45.

Quantification of HTLV-1 reverse transcriptase activity in ATL patients treated with zidovudine and interferon-α.

Macchi B, Balestrieri E, Frezza C, Grelli S, Valletta E, Marçais A, Marino-Merlo F, Turpin J, Bangham CR, Hermine O, Mastino A, Bazarbachi A.

Blood Adv. 2017 May 5;1(12):748-752. doi: 10.1182/bloodadvances.2016001370. eCollection 2017 May 9.

46.

Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia.

Bou-Fakhredin R, Bazarbachi AH, Chaya B, Sleiman J, Cappellini MD, Taher AT.

Int J Mol Sci. 2017 Dec 20;18(12). pii: E2778. doi: 10.3390/ijms18122778. Review.

47.

microRNA Expression in Ethnic Specific Early Stage Breast Cancer: an Integration and Comparative Analysis.

Nassar FJ, Talhouk R, Zgheib NK, Tfayli A, El Sabban M, El Saghir NS, Boulos F, Jabbour MN, Chalala C, Boustany RM, Kadara H, Zhang Z, Zheng Y, Joyce B, Hou L, Bazarbachi A, Calin G, Nasr R.

Sci Rep. 2017 Dec 4;7(1):16829. doi: 10.1038/s41598-017-16978-y.

48.

[Preventative and therapeutic relapse strategies after allogeneic hematopoietic stem cell transplantation: Guidelines from the Francophone society of bone marrow transplantation and cellular therapy (SFGM-TC)].

Yafour N, Beckerich F, Bulabois CE, Chevallier P, Daguindau É, Dumesnil C, Guillaume T, Huynh A, Levrat SM, Menard AL, Michallet M, Pautas C, Poiré X, Ravinet A, Yakoub-Agha I, Bazarbachi A.

Bull Cancer. 2017 Dec;104(12S):S84-S98. doi: 10.1016/j.bulcan.2017.05.009. Epub 2017 Nov 26. Review. French.

PMID:
29179894
49.

Progressive multifocal leukoencephalopathy in patients receiving rituximab and cyclophosphamide after haplo-identical T-cell replete transplantation and review of the literature.

Salem R, Massoud R, Kanj SS, Hamdan M, Salman R, Bazarbachi A, El-Cheikh J.

Curr Res Transl Med. 2017 Nov;65(4):127-132. doi: 10.1016/j.retram.2017.10.002. Epub 2017 Nov 10. Review.

PMID:
29132903
50.

Fludarabine-based reduced intensity regimen for matched related donor hematopoietic stem cell transplantation in acquired severe aplastic anemia.

Ghanem KM, Kharfan-Dabaja MA, El-Solh H, Harris N, Kreidieh N, Nehme R, Muwakkit SA, Saab R, Bazarbachi A, Abboud MR.

Curr Res Transl Med. 2017 Sep;65(3):115-119. doi: 10.1016/j.retram.2017.09.001. Epub 2017 Oct 4.

PMID:
28988743

Supplemental Content

Loading ...
Support Center